LOS ANGELES, Sept. 01, 2017 -- Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Arconic Inc. (“Arconic” or the “Company”) (NYSE:ARNC) (NYSE:ARNC-P) (NYSE:ARNC-PB) for possible violations of federal securities laws from February 28, 2017 through June 26, 2017, inclusive (the “Class Period”). Investors who purchased or otherwise acquired Arconic shares during the Class Period should contact the firm before the September 11, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here.
You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or e-mail him at [email protected].
No class has been certified in the above action yet, and until a class is certified, you are not considered to be represented by an attorney. You may choose to do nothing and be an absent class member as well.
The Complaint alleges that during the Class Period, Arconic made false and misleading statements, and/or failed to disclose: that the Company knowingly supplied its highly flammable Reynobond PE (polyethylene) cladding panels for use in construction; that this conduct significantly increased the risk of property damage, injury and/or death in buildings constructed with Arconic’s Reynobond PE panels; and that as a result, the Company’s public statements were materially false and misleading at all relevant times. When this news was announced, Arconic’s stock price fell materially, which caused investors harm according to the lawsuit.
Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.
This press release may constitute Attorney Advertising in certain jurisdictions under the applicable law and rules of ethics.
Contact: Lundin Law PC Brian Lundin, Esq. Telephone: 888-713-1033 Facsimile: 888-713-1125 [email protected] http://lundinlawpc.com/


Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Italy Fines Apple €98.6 Million Over App Store Dominance
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 



